Semaglutide Improves Daily Life for Patients with Diabetes and Kidney Disease

Updated at: June 4, 2026 at 01:20 PM

For adults managing both type 2 diabetes and chronic kidney disease, life can often feel like a constant struggle with health limitations.

nounadult

verbmanage

noundiabetes

However, exciting new data from the landmark FLOW trial brings a message of hope.

nounhope

Presented at the 63rd ERA Congress, the study revealed that once-weekly semaglutide does more than just protect kidney function; it significantly enhances a patient's overall quality of life.

nounstudy

verbprotect

nounquality

Results showed that while patients on a placebo saw their health utility scores decline over two years, those treated with semaglutide maintained stability.

nounstability

Patients reported improvements in mobility, self-care, and pain management.

nounmobility

Despite initial concerns that gastrointestinal side effects might hinder these gains, the study confirms that the benefits to physical functioning far outweigh these issues.

nounstudy

For both doctors and patients, this evidence highlights that treatment goals should include not just longevity, but the actual quality of daily life, proving semaglutide is a vital tool for those navigating these complex conditions.

nounquality

adjectivevital

🎉

End of article

You read 7 focus sentences.

Challenge Mode

Comprehension Questions

What is the primary benefit of semaglutide highlighted in the study beyond clinical markers?

It completely eliminates the need for any other diabetes medication.

It guarantees a total cure for chronic kidney disease.

It significantly improves the quality of daily life for patients.

Reveal Answer

✓

Correct Choice

It significantly improves the quality of daily life for patients.

How did the health utility scores of the semaglutide group compare to the placebo group after two years?

Both groups experienced an identical decline in their health scores.

The placebo group showed higher scores than the semaglutide group.

The semaglutide group maintained stable scores while the placebo group declined.

Reveal Answer

✓

Correct Choice

The semaglutide group maintained stable scores while the placebo group declined.

How is the 'practical impact' of the treatment described in the study?

It is equivalent to roughly eight additional days of full health per year.

Patients required eight fewer daily doses of medication.

Patients saved eight hours of clinical visit time each year.

Reveal Answer

✓

Correct Choice

It is equivalent to roughly eight additional days of full health per year.

Which potential side effects did researchers worry might negatively impact quality of life?

Chronic fatigue and skin rashes.

Cognitive decline and sleep disorders.

Gastrointestinal side effects.

Reveal Answer

✓

Correct Choice

Gastrointestinal side effects.

What does the FLOW trial suggest about treatment goals for patients with T2D and CKD?

Clinical markers should be prioritized exclusively over patient-reported well-being.

Longevity is the only factor that clinicians should discuss with patients.

Quality of life is just as important as longevity in treatment planning.

Reveal Answer

✓

Correct Choice

Quality of life is just as important as longevity in treatment planning.

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.

App Store Google Play